{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:50:38Z","timestamp":1770749438506,"version":"3.50.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Neurology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/s1474-4422(07)70219-3","type":"journal-article","created":{"date-parts":[[2007,8,14]],"date-time":"2007-08-14T11:53:21Z","timestamp":1187092401000},"page":"830-838","source":"Crossref","is-referenced-by-count":189,"title":["Homocysteine-lowering therapy: a role in stroke prevention?"],"prefix":"10.1016","volume":"6","author":[{"given":"J David","family":"Spence","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1474-4422(07)70219-3_bib1","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1161\/01.ATV.20.7.1704","article-title":"Homocysteine and its disulfide derivatives: a suggested consensus terminology","volume":"20","author":"Mudd","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/adc.37.195.505","article-title":"Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland","volume":"37","author":"Carson","year":"1962","journal-title":"Arch Dis Child"},{"key":"10.1016\/S1474-4422(07)70219-3_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0006-291X(62)90114-6","article-title":"The identification of homocystine in the urine","volume":"9","author":"Gerritsen","year":"1962","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S1474-4422(07)70219-3_bib4","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of atherosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am J Pathol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM198509193131201","article-title":"Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease","volume":"313","author":"Boers","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib6","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-2000-8470","article-title":"Genetic modulation of homocysteinemia","volume":"26","author":"Rozen","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/S1474-4422(07)70219-3_bib8","first-page":"173","article-title":"Nutritional and metabolic aspects of stroke prevention","volume":"92","author":"Spence","year":"2003","journal-title":"Adv Neurol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1399-0004.2004.00250.x","article-title":"Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration","volume":"65","author":"Wang","year":"2004","journal-title":"Clin Genet"},{"key":"10.1016\/S1474-4422(07)70219-3_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000013486","article-title":"Effect of usual doses of folate supplementation on elevated plasma homocyst(e)ine in hemodialysis patients: no difference between 1 and 5 mg daily","volume":"18","author":"Spence","year":"1999","journal-title":"Am J Nephrol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib11","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1096\/fasebj.7.14.7901104","article-title":"Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency","volume":"7","author":"Allen","year":"1993","journal-title":"FASEB J"},{"key":"10.1016\/S1474-4422(07)70219-3_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/ajcn\/67.2.263","article-title":"Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study","volume":"67","author":"Nygard","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S1474-4422(07)70219-3_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2165\/00003495-200262040-00005","article-title":"Drugs affecting homocysteine metabolism: impact on cardiovascular risk","volume":"62","author":"Desouza","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/S1474-4422(07)70219-3_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-2005-872398","article-title":"Effect of drugs on homocysteine concentrations","volume":"5","author":"Dierkes","year":"2005","journal-title":"Semin Vasc Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib15","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1079\/BJN20061764","article-title":"Antioxidant activity of vitamin B6 delays homocysteine-induced atherosclerosis in rats","volume":"95","author":"Endo","year":"2006","journal-title":"Br J Nutr"},{"key":"10.1016\/S1474-4422(07)70219-3_bib16","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.ATV.0000035404.18281.37","article-title":"Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules","volume":"22","author":"Wang","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib17","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI11596","article-title":"Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways","volume":"107","author":"Werstuck","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/S1474-4422(07)70219-3_bib18","doi-asserted-by":"crossref","first-page":"30317","DOI":"10.1074\/jbc.M212897200","article-title":"TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the development of atherosclerosis in hyperhomocysteinemia","volume":"278","author":"Hossain","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/S1474-4422(07)70219-3_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.0000134487.51510.97","article-title":"Association of multiple cellular stress pathways with accelerated atherosclerosis in hyperhomocysteinemic apolipoprotein E-deficient mice","volume":"110","author":"Zhou","year":"2004","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1016\/S1474-4422(07)70219-3_bib20","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1038\/sj.cdd.4401451","article-title":"Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease","volume":"11","author":"Austin","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1016\/S1474-4422(07)70219-3_bib21","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","article-title":"Plasma homocysteine as a risk factor for vascular disease","volume":"277","author":"Graham","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/S1474-4422(07)70219-3_bib22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","article-title":"Plasma homocysteine levels and mortality in patients with coronary artery disease","volume":"337","author":"Nyg\u00e5rd","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering plasma total homocysteine to prevent recurrent stroke, myocardial infarction, and death in ischemic stroke patients: results of the Vitamin Intervention for Stroke Prevention (VISP) Randomized Trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S1474-4422(07)70219-3_bib24","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib25","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(05)17742-3","article-title":"Homocysteine and stroke: evidence on a causal link from mendelian randomisation","volume":"365","author":"Casas","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(07)70219-3_bib27","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/01.STR.0000169946.31639.af","article-title":"Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis","volume":"36","author":"Cronin","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/S1474-4422(07)70219-3_bib28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.STR.30.5.969","article-title":"Plasma homocyst(e)ine, but not MTHFR genotype, is associated with variation in carotid plaque area","volume":"30","author":"Spence","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/S1474-4422(07)70219-3_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00062752-199809000-00007","article-title":"Mechanisms of thrombosis in hyperhomocysteinemia","volume":"5","author":"Lentz","year":"1998","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib30","first-page":"917","article-title":"Hyperhomocysteinemia, thrombosis and vascular biology","volume":"50","author":"Ebbesen","year":"2004","journal-title":"Cell Mol Biol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1160\/TH05-05-0313","article-title":"Homocysteine and thrombosis: from basic science to clinical evidence","volume":"94","author":"Undas","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/S1474-4422(07)70219-3_bib32","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1172\/JCI116712","article-title":"Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells","volume":"92","author":"Nishinaga","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/S1474-4422(07)70219-3_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000090635","article-title":"Methionine-induced elevation of plasma homocysteine concentration is associated with an increase of plasma cholesterol in adult rats","volume":"50","author":"Hirche","year":"2006","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/S1474-4422(07)70219-3_bib34","doi-asserted-by":"crossref","first-page":"E1002","DOI":"10.1152\/ajpendo.00518.2004","article-title":"Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors","volume":"288","author":"Woo","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S1474-4422(07)70219-3_bib35","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/hc0902.104713","article-title":"Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme a reductase in vascular endothelial cells: a mechanism for development of atherosclerosis?","volume":"105","author":"Li","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/S1474-4422(07)70219-3_bib36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2006.05.009","article-title":"Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model","volume":"45","author":"Ji","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib37","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1172\/JCI116187","article-title":"Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen","volume":"91","author":"Stamler","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/S1474-4422(07)70219-3_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1753-4887.1996.tb03770.x","article-title":"Biological chemistry of thiols in the vasculature and in vascular-related disease","volume":"54","author":"Stamler","year":"1996","journal-title":"Nutr Rev"},{"key":"10.1016\/S1474-4422(07)70219-3_bib39","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.RES.0000242559.42077.22","article-title":"Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I protein synthesis and enhancing HDL cholesterol clearance","volume":"99","author":"Liao","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/S1474-4422(07)70219-3_bib40","first-page":"28","article-title":"[Effect of vitamin therapy on homocyst(e)ine, fibrinogen and Lp(a) in dialysis patients]","volume":"4","author":"Klinke","year":"1998","journal-title":"Czynniki Ryzyka Suppl"},{"key":"10.1016\/S1474-4422(07)70219-3_bib41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<28::AID-JCP4>3.0.CO;2-O","article-title":"Homocyst(e)ine induces calcium second messenger in vascular smooth muscle cells","volume":"183","author":"Mujumdar","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib42","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.ATV.0000014221.30108.08","article-title":"Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion","volume":"22","author":"Silverman","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib43","doi-asserted-by":"crossref","first-page":"35867","DOI":"10.1074\/jbc.M100747200","article-title":"Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response","volume":"276","author":"Zhang","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S1474-4422(07)70219-3_bib44","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.HYP.0000127914.94292.76","article-title":"Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways","volume":"43","author":"Suhara","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/S1474-4422(07)70219-3_bib45","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/01.CIR.0000085067.55901.89","article-title":"Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine","volume":"108","author":"Stuhlinger","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/S1474-4422(07)70219-3_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000090947","article-title":"Homocysteine-induced endothelin-1 release is dependent on hyperglycaemia and reactive oxygen species production in bovine aortic endothelial cells","volume":"43","author":"Sethi","year":"2006","journal-title":"J Vasc Res"},{"key":"10.1016\/S1474-4422(07)70219-3_bib47","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1046\/j.0014-2956.2001.02460.x","article-title":"Homocysteine-induced decrease in endothelin-1 production is initiated at the extracellular level and involves oxidative products","volume":"268","author":"Drunat","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/S1474-4422(07)70219-3_bib48","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/hq0901.096582","article-title":"Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice","volume":"21","author":"Zhou","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib49","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/01.ATV.0000251607.96118.af","article-title":"Prothrombotic effects of hyperhomocysteinemia and hypercholesterolemia in ApoE-deficient mice","volume":"27","author":"Wilson","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib50","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2362.1995.tb01545.x","article-title":"Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease","volume":"25","author":"Van den Berg","year":"1995","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/S1474-4422(07)70219-3_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(05)78090-9","article-title":"Acute hyperhomocysteinaemia and endothelial dysfunction","volume":"351","author":"Chambers","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(07)70219-3_bib52","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/clc.4960251105","article-title":"Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation","volume":"25","author":"Hirsch","year":"2002","journal-title":"Clin Cardiol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib53","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1515\/CCLM.2003.231","article-title":"Folate improves endothelial function in patients with coronary heart disease","volume":"41","author":"Doshi","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.0000109492.65802.AD","article-title":"Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure","volume":"109","author":"Scholze","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/S1474-4422(07)70219-3_bib55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2005-872401","article-title":"Mechanisms of the atherogenic effects of elevated homocysteine in experimental models","volume":"5","author":"Wilson","year":"2005","journal-title":"Semin Vasc Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib56","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/01.ATV.0000251607.96118.af","article-title":"Prothrombotic effects of hyperhomocysteinemia and hypercholesterolemia in ApoE-deficient mice","volume":"27","author":"Wilson","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib57","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI11596","article-title":"Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways","volume":"107","author":"Werstuck","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/S1474-4422(07)70219-3_bib58","doi-asserted-by":"crossref","first-page":"30317","DOI":"10.1074\/jbc.M212897200","article-title":"TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the cevelopment of atherosclerosis in hyperhomocysteinemia","volume":"278","author":"Hossain","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/S1474-4422(07)70219-3_bib59","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.0000134487.51510.97","article-title":"Association of multiple cellular stress pathways with accelerated atherosclerosis in hyperhomocysteinemic apolipoprotein E-deficient mice","volume":"110","author":"Zhou","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/S1474-4422(07)70219-3_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/01.ATV.0000251536.49581.8a","article-title":"Targeting of metallothionein by L-homocysteine: a novel mechanism for disruption of zinc and redox homeostasis","volume":"27","author":"Barbato","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.ATV.0000254151.00086.26","article-title":"Homocysteinylation of metallothionein impairs intracellular redox homeostasis: the enemy within!","volume":"27","author":"Colgan","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib62","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ejvs.2005.05.034","article-title":"Thrombophilia testing in patients with venous thrombosis","volume":"30","author":"Caprini","year":"2005","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/S1474-4422(07)70219-3_bib63","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/0003-4819-131-7-199910050-00033","article-title":"Ocular venous occlusion and hyperhomocysteinemia","volume":"131","author":"Ducloux","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib64","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000083825","article-title":"Homocysteine, vitamin B6 and the risk of recurrent venous thromboembolism","volume":"33","author":"Eichinger","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/S1474-4422(07)70219-3_bib65","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ajh.20131","article-title":"Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects","volume":"76","author":"Hendler","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0049-3848(02)00191-3","article-title":"Effects of homocysteine thiol group on fibrin networks: another possible mechanism of harm","volume":"107","author":"Lauricella","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/S1474-4422(07)70219-3_bib67","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1172\/JCI115514","article-title":"Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent, homocysteine","volume":"88","author":"Lentz","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/S1474-4422(07)70219-3_bib68","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1161\/01.STR.0000183620.06179.7b","article-title":"Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine","volume":"36","author":"Poli","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/S1474-4422(07)70219-3_bib69","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/hs0202.103069","article-title":"Changes in plasma homocyst(e)ine in the acute phase after stroke","volume":"33","author":"Howard","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/S1474-4422(07)70219-3_bib70","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/archinte.158.13.1461","article-title":"Fluctuations in blood lipid levels during furosemide therapy: a randomized, double-blind, placebo-controlled crossover study","volume":"158","author":"Campbell","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib71","first-page":"350","article-title":"Effect on lipid, complete blood count and blood proteins of a standardized preparation for drawing blood: a randomized controlled trial","volume":"23","author":"Campbell","year":"2000","journal-title":"Clin Invest Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib72","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/01.CIR.102.20.2479","article-title":"Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine","volume":"102","author":"Chambers","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/S1474-4422(07)70219-3_bib73","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(05)78275-1","article-title":"Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia","volume":"351","author":"Peterson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(07)70219-3_bib74","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0895-7061(99)00180-6","article-title":"What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micromol\/L","volume":"13","author":"Hackam","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/S1474-4422(07)70219-3_bib75","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0167-5273(03)00168-2","article-title":"Effect of homocysteine-lowering vitamin treatment on electrocardiography stress tests in a randomized, placebo-controlled trial: comparison between ST-segment changes and Athen QRS-score","volume":"93","author":"Vermeulen","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib76","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/01.TP.0000058810.59825.58","article-title":"Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients","volume":"75","author":"Marcucci","year":"2003","journal-title":"Transplantation"},{"issue":"suppl","key":"10.1016\/S1474-4422(07)70219-3_bib77","doi-asserted-by":"crossref","first-page":"1731S","DOI":"10.1093\/jn\/136.6.1731S","article-title":"The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease","volume":"136","author":"Refsum","year":"2006","journal-title":"J Nutr"},{"key":"10.1016\/S1474-4422(07)70219-3_bib78","first-page":"189","article-title":"Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina","volume":"5","author":"Ortolani","year":"2004","journal-title":"Ital Heart J"},{"key":"10.1016\/S1474-4422(07)70219-3_bib79","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJMoa011364","article-title":"Decreased rate of coronary restenosis after lowering of plasma homocysteine levels","volume":"345","author":"Schnyder","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib80","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.288.8.973","article-title":"Effect of homocysteine-lowering therapy with folic acid, vitamin B(12), and vitamin B(6) on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial","volume":"288","author":"Schnyder","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S1474-4422(07)70219-3_bib81","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1056\/NEJMoa032845","article-title":"Folate therapy and in-stent restenosis after coronary stenting","volume":"350","author":"Lange","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib82","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S1474-4422(07)70219-3_bib83","first-page":"207","article-title":"Homocysteine, B vitamins, and cardiovascular disease","volume":"355","author":"Refsum","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib84","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/S1474-4422(07)70219-3_bib85","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000054753","article-title":"Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and design","volume":"20","author":"Spence","year":"2001","journal-title":"Neuroepidemiology"},{"key":"10.1016\/S1474-4422(07)70219-3_bib86","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1046\/j.1532-5415.2002.50506.x","article-title":"Response of elevated methylmalonic acid to three dose levels of oral cobalamin in older adults","volume":"50","author":"Rajan","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S1474-4422(07)70219-3_bib87","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/01.STR.0000185929.38534.f3","article-title":"Vitamin Intervention For Stroke Prevention trial: an efficacy analysis","volume":"36","author":"Spence","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/S1474-4422(07)70219-3_bib88","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMe068060","article-title":"Homocysteine trials\u2014clear outcomes for complex reasons","volume":"354","author":"Loscalzo","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib89","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.296.22.2720","article-title":"Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"296","author":"Bazzano","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S1474-4422(07)70219-3_bib90","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(07)60854-X","article-title":"Efficacy of folic acid supplementation in stroke prevention: a meta-analysis","volume":"369","author":"Wang","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(07)70219-3_bib91","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIRCULATIONAHA.106.179918","article-title":"Heart disease and stroke statistics\u20142007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"115","author":"Rosamond","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/S1474-4422(07)70219-3_bib92","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1503\/cmaj.1031155","article-title":"Vitamin B12 (cobalamin) deficiency in elderly patients","volume":"171","author":"Andres","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/S1474-4422(07)70219-3_bib93","first-page":"332","article-title":"Depletion of serum holotranscobalamin II. An early sign of negative vitamin B12 balance","volume":"58","author":"Herzlich","year":"1988","journal-title":"Lab Invest"},{"key":"10.1016\/S1474-4422(07)70219-3_bib94","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1532-5415.1997.tb01494.x","article-title":"Holotranscobalamin II levels in plasma are related to dementia in older people","volume":"45","author":"Johnston","year":"1997","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S1474-4422(07)70219-3_bib95","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2362.1999.00446.x","article-title":"Holotranscobalamin\u2014a sensitive marker of cobalamin malabsorption","volume":"29","author":"Lindgren","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/S1474-4422(07)70219-3_bib96","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM199905133401901","article-title":"The effect of folic acid fortification on plasma folate and total homocysteine concentrations","volume":"340","author":"Jacques","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib97","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1503\/cmaj.045055","article-title":"Increased importance of vitamin B12 for total homocysteine and carotid plaque in the era of folate fortification of the grain supply","volume":"172","author":"Robertson","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/S1474-4422(07)70219-3_bib98","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1161\/01.STR.0000236633.40160.ee","article-title":"Nutrition and stroke prevention","volume":"37","author":"Spence","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/S1474-4422(07)70219-3_bib99","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(02)07439-1","article-title":"Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease","volume":"359","author":"Quinlivan","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S1474-4422(07)70219-3_bib100","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1515\/CCLM.2005.202","article-title":"The vegetarian lifestyle and DNA methylation","volume":"43","author":"Geisel","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/S1474-4422(07)70219-3_bib101","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.ejcn.1601337","article-title":"The impact on eating habits of temporary translocation from a mediterranean to a northern European environment","volume":"56","author":"Papadaki","year":"2002","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S1474-4422(07)70219-3_bib102","first-page":"182","article-title":"Occult cobalamin and folate deficiency in Indians","volume":"18","author":"Khanduri","year":"2005","journal-title":"Natl Med J India"},{"key":"10.1016\/S1474-4422(07)70219-3_bib103","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ajh.10093","article-title":"Hyperhomocysteinemia and cobalamin deficiency in young Asian Indians in the United States","volume":"70","author":"Carmel","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib104","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1093\/jn\/133.12.4135","article-title":"Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women","volume":"133","author":"Olthof","year":"2003","journal-title":"J Nutr"},{"key":"10.1016\/S1474-4422(07)70219-3_bib105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ajcn\/82.1.111","article-title":"Choline supplemented as phosphatidylcholine decreases fasting and postmethionine-loading plasma homocysteine concentrations in healthy men","volume":"82","author":"Olthof","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S1474-4422(07)70219-3_bib106","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1373\/clinchem.2003.021634","article-title":"Facts and recommendations about total homocysteine determinations: an expert opinion","volume":"50","author":"Refsum","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/S1474-4422(07)70219-3_bib107","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1681\/ASN.V131265","article-title":"Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis","volume":"13","author":"Friedman","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib108","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/j.ajkd.2004.06.010","article-title":"Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial","volume":"44","author":"House","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S1474-4422(07)70219-3_bib109","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/jps.20680","article-title":"Thiol exchange: an in vitro assay that predicts the efficacy of novel homocysteine lowering therapies","volume":"95","author":"Urquhart","year":"2006","journal-title":"J Pharm Sci"},{"key":"10.1016\/S1474-4422(07)70219-3_bib110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/j.ajkd.2006.10.002","article-title":"The effect of mesna on plasma total homocysteine concentration in hemodialysis patients","volume":"49","author":"Urquhart","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S1474-4422(07)70219-3_bib111","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/ncpneuro0093","article-title":"Is plasma homocysteine a modifiable risk factor for stroke?","volume":"2","author":"Hankey","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/S1474-4422(07)70219-3_bib112","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1055\/s-2006-933306","article-title":"Homocyst(e)ine and stroke","volume":"26","author":"Furie","year":"2006","journal-title":"Semin Neurol"},{"issue":"6 suppl","key":"10.1016\/S1474-4422(07)70219-3_bib113","doi-asserted-by":"crossref","first-page":"1726S","DOI":"10.1093\/jn\/136.6.1726S","article-title":"The many facets of hyperhomocysteinemia: studies from the Framingham cohorts","volume":"136","author":"Selhub","year":"2006","journal-title":"J Nutr"}],"container-title":["The Lancet Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442207702193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442207702193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T18:40:30Z","timestamp":1629571230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1474442207702193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":113,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1474442207702193"],"URL":"https:\/\/doi.org\/10.1016\/s1474-4422(07)70219-3","relation":{},"ISSN":["1474-4422"],"issn-type":[{"value":"1474-4422","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}